Figure 2From: A pilot study of bevacizumab combined with etoposide and cisplatin in breast cancer patients with leptomeningeal carcinomatosisThe effects of bevacizumab administration on the temporal changes of CSF to plasma ratio of etoposide concentration. (A) Individual CSF/ Plasma ratio of etoposide concentration versus time plot. (B) Overall CSF/Plasma ratio of etoposide concentration versus time plot.Back to article page